ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,207, issued on Sept. 30, was assigned to Blue Earth Diagnostics Ltd. (Oxford, Great Britain) and Siemens Medical Solutions USA Inc..

"Pharmaceutical formulations" was invented by Romain Bejot (Oxford, Great Britain), Michael Haka (Knoxville, Tenn.) and Atilio Anzellotti (Oak Ridge, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a ph of 4.0-6.0 and further comprises: 0.1-200 mM ...